A single German center experience with intermittent inotropes for patients on the high-urgent heart transplant waiting list

Inotropic agents in advanced heart failure: Repetita iuvant?

(2014) Leonardo De Luca   INTERNATIONAL JOURNAL OF CARDIOLOGY

Treatment with inotropes and related prognosis in acute heart failure: Contemporary data from the Italian Network on Heart Failure (IN-HF) Outcome registry

(2014) Andrea Mortara et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary

(2013) Clyde W. Yancy et al.   CIRCULATION

Intermittent levosimendan improves mid-term survival in chronic heart failure patients: meta-analysis of randomised trials

(2013) Simona Silvetti et al.   Clinical Research in Cardiology

Intermittent levosimendan treatment in patients with severe congestive heart failure

(2013) Petri O. Tuomainen et al.   Clinical Research in Cardiology

Mortality in a cardiac intensive care unit

(2012) Carsten Zobel et al.   Clinical Research in Cardiology

Intermittent Levosimendan Infusions in Advanced Heart Failure

(2012) Gabriella Malfatto et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Comparison of three different regimens of intermittent inotrope infusions for end stage heart failure

(2011) Michael J. Bonios et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers

(2010) Claes-Håkan Bergh et al.   EUROPEAN JOURNAL OF HEART FAILURE

Early On–Cardiopulmonary Bypass Hypotension and Other Factors Associated With Vasoplegic Syndrome

(2009) Matthew A. Levin et al.   CIRCULATION

Prognosis on Chronic Dobutamine or Milrinone Infusions for Stage D Heart Failure

(2009) Eiran Z. Gorodeski et al.   Circulation-Heart Failure

Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond

(2009) John R. Teerlink et al.   HEART FAILURE REVIEWS